Drug Trial Radar · NCT06799559
Study on the Efficacy and Safety of QLM1016 in Schizophrenia
Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
402
Planned (sponsor's estimate)
Start
Oct 2, 2025
Primary completion
Oct 23, 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Qilu Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jan 29, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will evaluate the antipsychotic efficacy of QLM1016 in a multicenter, randomized, double-blind, parallel controlled study in patients diagnosed with schizophrenia.
Conditions
- Schizophrenia
Interventions
3-6mg QLM1016Drug
3-6mg QLM1016 pluse Aripiprazole dummy oral solution film administered orally once daily for 6 weeks
10-20 mg Aripiprazole oral solution filmDrug
10-20mg Aripiprazole oral solution film plus QLM1016 dummy oral solution film administered orally once daily for 6 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- change from baseline to week 6 in the Positive and Negative Syndrome Scale (PANSS) total scoreTime frame: Time Frame: 6 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
No. 8888 Lvyou Road
Jinan, Shandong, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.